Connor, Clark & Lunn Investment Management (CC&L)
ADPT icon

Connor, Clark & Lunn Investment Management (CC&L)’s Adaptive Biotechnologies ADPT Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio ADPT Stock Details ADPT Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$837K Buy
2023
Q1 		– Sell
2022
Q4 		$681K Sell
2022
Q3 		$1.92M Buy
2022
Q2 		$1.09M Buy
2022
Q1 		$295K Buy
2021
Q4 		$505K Sell
2021
Q3 		$801K Buy